CJC-1295
A growth hormone-releasing peptide used at SSK Longevity in Newport Beach, California, for recovery, body composition, sleep quality, and longevity protocols.
A Foundational Growth Hormone-Releasing Peptide
CJC-1295 is a modified analog of growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release the body's own growth hormone, amplifying natural pulses rather than replacing growth hormone directly. It is sometimes paired with Ipamorelin, a selective GHRP; learn more in our Ipamorelin Guide and CJC-1295 Guide.
At SSK Longevity in Newport Beach, CJC-1295 is prescribed by Dr. Sean Kelishadi, MD FACS and compounded under Sherry Kelishadi, Pharm.D.'s direct pharmacy oversight for Orange County patients.
How CJC-1295 Works
CJC-1295 works upstream of growth hormone. By activating the GHRH receptor on the pituitary, it increases the size and duration of natural growth hormone pulses, which in turn raises IGF-1. Because it relies on the body's own signaling, monitoring and cycling are central to every protocol.
GHRH Receptor Activation
CJC-1295 is a modified analog of growth hormone-releasing hormone (GHRH). It binds the GHRH receptor on the pituitary gland and signals it to release the body's own growth hormone.
Amplified Natural GH Pulses
Rather than replacing growth hormone, CJC-1295 increases the amplitude and duration of the natural pulses your pituitary already produces, with corresponding increases in IGF-1.
Optional GHRP Pairing
CJC-1295 is sometimes paired with a GHRP such as Ipamorelin, which works through a separate receptor. Whether a pairing is appropriate is decided individually.
CJC-1295, Compounded for Your Cycle
Every CJC-1295 protocol at SSK Longevity Newport Beach is compounded under Sherry Kelishadi, Pharm.D.'s direct review. Dose ratios, injection timing, and complementary peptide layering are evaluated individually for each patient.
Newport Beach, Costa Mesa, Irvine, and Orange County patients receive a CJC-1295 protocol calibrated to their physiology, training schedule, and longevity goals.
Individual results are not guaranteed and may vary from person to person.
- Personalized lab review and metabolic assessment
- Compounded under Pharm.D. supervision in Newport Beach
- Individualized dose protocols tailored to your physiology
- Drug interaction review before anything is dispensed
- Direct physician access throughout treatment
- Coordinated care with complementary protocols when appropriate
Peptides Layered With CJC-1295
Patients on CJC-1295 in Newport Beach often layer or transition to these complementary peptide protocols for cellular health, recovery, and longevity depth.
Peptide Therapy Stacked With Growth Hormone Secretagogues
CJC-1295 is rarely the whole protocol. SSK Longevity Newport Beach patients commonly layer it with weight management, recovery, or hormonal protocols. Sherry Kelishadi, Pharm.D. coordinates every combined protocol individually before dispensing.
Tesamorelin
A stabilized GHRH analog, FDA-approved as Egrifta for a specific indication, often considered when body composition and visceral fat are the focus.
Learn More →MOTS-c
Mitochondrial-derived peptide layered with CJC-1295 for cellular energy, metabolic regulation, and longevity depth.
Learn More →Epithalon
Telomere-supportive peptide commonly cycled alongside CJC-1295 in longevity protocols at SSK Longevity.
Learn More →CJC-1295 Benefits at SSK Longevity in Newport Beach, CA
CJC-1295 at SSK Longevity in Newport Beach is used to support sleep quality, recovery, lean mass preservation, and longevity-relevant outcomes. It is compounded under Pharm.D. oversight for patients across Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, Corona del Mar, and Orange County. Below are the outcomes CJC-1295 patients commonly report.
Improved Recovery
Patients commonly report faster recovery from training, reduced soreness, and improved sleep depth — driven by improved nighttime growth hormone release.
Body Composition Support
Sustained physiologic growth hormone release supports lean mass preservation and fat metabolism during weight loss or training cycles.
Deeper Sleep Quality
Patients consistently report deeper, more restorative sleep — reflecting the natural growth hormone surge that occurs during slow-wave sleep.
Skin Quality & Collagen
Growth hormone supports collagen synthesis and skin quality, complementary to aesthetic protocols at SSK.
Stamina & Energy
Patients describe steadier energy and improved exercise tolerance over the course of a 3-6 month protocol cycle.
Cellular Recovery & Repair
Improved tissue turnover supports recovery from injury, training, and overall longevity-focused goals.
Is CJC-1295 Right For You?
CJC-1295 at SSK Longevity Newport Beach is appropriate for adults seeking medically supervised peptide therapy with physician oversight, lab-driven protocol design, and Pharm.D.-supervised compounding. Patients pursuing this protocol typically fit one or more of the profiles below.
Conditions Treated Alongside CJC-1295 in Newport Beach
How CJC-1295 Cycles Are Built at SSK Longevity
Comprehensive Consultation
Lab review, medical history, and goals discussion with the SSK Longevity team in Newport Beach.
Personalized Protocol
CJC-1295 dosing, injection timing, protocol length, and whether any pairing is appropriate, calibrated to your physiology and goals.
Pharmacist Compounding
Sherry Kelishadi, Pharm.D. oversees every compounded CJC-1295 vial dispensed by SSK Longevity.
Ongoing Clinical Oversight
Scheduled follow-ups, lab rechecks, and dose adjustments calibrated to your response over time.
CJC-1295 Safety, IGF-1 Monitoring, and Cycling
CJC-1295 therapy under proper medical supervision has a well-characterized safety profile, but real considerations deserve direct discussion before any Newport Beach patient begins a protocol.
-
—
Mild injection-site reactions Localized redness, irritation, or discomfort at the injection site are most common. Typically self-limited and improve with rotation of injection sites.
-
—
IGF-1 elevation requires monitoring CJC-1295 elevates IGF-1 levels. Pre-protocol baseline and follow-up IGF-1 testing help keep levels within physiologically appropriate ranges.
-
—
Contraindicated in active malignancy Growth hormone elevation is generally avoided in patients with active or recent malignancy. Cancer history is screened during initial evaluation.
-
—
Glucose monitoring during long cycles Sustained GH elevation can affect insulin sensitivity. Glucose and HbA1c are monitored, particularly in patients with metabolic risk factors.
-
—
Cycling is typical, not continuous use Most protocols cycle 3-6 months on, followed by an off period. Continuous long-term use is reserved for specific clinical situations under careful monitoring.
-
—
Not appropriate during pregnancy or breastfeeding Growth hormone secretagogues are not used during pregnancy or breastfeeding. Adequate planning is required for patients of reproductive age.
What patients actually say.
"My recovery from training is night and day. The team at SSK got my dosing right and my sleep has never been better."
"I started CJC/Ipamorelin alongside my Tirzepatide protocol to protect lean mass. Sherry walked me through the layering carefully."
"What stood out was the lab-driven approach. They watched my IGF-1 and adjusted my protocol over time. Felt like real medicine, not a peptide refill."
From Our Founders
CJC-1295 is one of the most reliably useful growth peptides we prescribe at SSK Longevity. It works with the body's own pituitary signaling rather than replacing growth hormone, which is why careful lab monitoring and cycling are central to how we use it.
Patients deserve compounded medications calibrated to their specific physiology. Every CJC-1295 protocol we dispense at SSK Longevity is reviewed for dosing, sourcing, and interactions, including how it fits with anything else a patient is taking.
Why Newport Beach Trusts SSK Longevity For Growth Peptide Therapy
CJC-1295 FAQ for Newport Beach & Orange County
Is CJC-1295 the same as HGH?
No. CJC-1295 stimulates the body's own pituitary release of growth hormone. It does not introduce exogenous HGH directly into the bloodstream.
Is CJC-1295 FDA-approved?
No. CJC-1295 is not FDA-approved for any indication. In December 2024, FDA's Pharmacy Compounding Advisory Committee voted against adding it to the list of substances eligible for compounding. Regulatory status is discussed openly with every patient before treatment.
Can CJC-1295 be combined with Ipamorelin?
Yes. CJC-1295 is sometimes paired with Ipamorelin, a GHRP that stimulates growth hormone release through a different receptor. Whether a pairing is appropriate depends on your goals, labs, and history, and is decided with your physician.
How is CJC-1295 layered with weight loss medications?
Many SSK Longevity patients combine CJC-1295 with Semaglutide or Tirzepatide to preserve lean mass during weight loss. Layering is always reviewed by Sherry Kelishadi, Pharm.D. for safety and clinical fit.
What labs are monitored during treatment?
IGF-1 is the primary marker monitored during longer protocol cycles. Comprehensive metabolic and hormone panels may be checked periodically depending on your individualized protocol.
How is CJC-1295 injected?
CJC-1295 is given as a subcutaneous injection. Frequency depends on the formulation and your protocol; many protocols use a bedtime injection to align with the body's natural growth hormone release. Most patients follow a 3-6 month protocol cycle, individualized based on goals, response, and lab markers.
What are the most common side effects?
Most patients tolerate the protocol well. Possible side effects include injection-site irritation, mild flushing, and occasional water retention during early cycles.
Where is SSK Longevity located?
SSK Longevity is in Newport Beach, California, at 500 Superior Avenue, Suite 340 — serving patients across Orange County including Costa Mesa, Irvine, Huntington Beach, and Laguna Beach.
Treatments Stacked With Growth Peptides at SSK Longevity
CJC-1295 is not FDA-approved for any indication. It is prescribed off-label under physician supervision and compounded under physician oversight. The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapy requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight. Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance. Payment options and financing are available. Individual results are not guaranteed and may vary from person to person. All treatments are administered under the supervision of a licensed physician.